Concepedia

Preparation and Biological Evaluation of <sup>64</sup>Cu-CB-TE2A-sst<sub>2</sub>-ANT, a Somatostatin Antagonist for PET Imaging of Somatostatin Receptor–Positive Tumors

Thaddeus J. Wadas, Martin Eiblmaier, Alexander Zheleznyak, Christopher D. Sherman, Riccardo Ferdani, Kexian Liang, Samuel Achilefu, Carolyn J. Anderson

Journal of Nuclear Medicine · 2008 · 74 citations · 26 references

DOIFull text

Open access

Abstract

The PET radiopharmaceutical 64Cu-CB-TE2A-sst2-ANT is an attractive agent, worthy of future study as a PET radiopharmaceutical for the imaging of somatostatin receptor-positive tumors.

References

26

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

Jean Claude Reubi, Jean-Claude Schär, Beatrice Waser et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2000 · 1.1K citations

, , +6

Efficient production of high specific activity 64Cu using a biomedical cyclotron

Deborah W. McCarthy, R. E. Shefer, R. E. Klinkowstein et al. · Nuclear Medicine and Biology · 1997 · 524 citations

, , +6

Radiolabeled somatostatin receptor antagonists are preferable to agonists for<i>in vivo</i>peptide receptor targeting of tumors

Mihaela Ginj, Hanwen Zhang, Beatrice Waser et al. · Proceedings of the National Academy of Sciences · 2006 · 488 citations · Full text

, , +22

Comparative in Vivo Stability of Copper-64-Labeled Cross-Bridged and Conventional Tetraazamacrocyclic Complexes

C. Andrew Boswell, Xiankai Sun, Weijun Niu et al. · Journal of Medicinal Chemistry · 2004 · 476 citations

64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.

Carolyn J. Anderson, Farrokh Dehdashti, Paul Cutler et al. · PubMed · 2001 · 275 citations